Clinical trial results of Pfizer/BioNTech’s Covid-19 vaccine showed its efficacy…
Clinical trial results of Pfizer/BioNTech’s Covid-19 vaccine showed its efficacy is 100% and it is well tolerated in youths ages 12 to 15, the companies said Wednesday. The vaccine is currently authorized in the US for emergency use in people 16 and older. “The bottom line is that by the fall I think there’s a good possibility we’ll be vaccinating teenagers, 12 and up,” said Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital, noting that the vaccine will still need to be evaluated for authorization in that age group.
(📸: Antonio Masiello/Getty Images)
Credit to the Original Source